About Cytarabine Injection
Cytarabine injection bp 500 mg and 1 gm might be utilized alone or in mix with other antineoplastic operators. It is demonstrated alone or in blend for acceptance of abatement as well as support in patients with intense myeloid leukemia, intense non-lymphoblastic leukaemias, intense lymphoblastic leukaemias, intense lymphocytic leukemia, erythroleukaemia, shoot emergencies of incessant myeloid leukemia, diffuse histiocytic lymphomas (non-hodgkin's lymphomas of high harm), meningeal leukemia and meningeal neoplasms.
It is produced by numerous indian makers including brands like united biotech limited etc.To Know more get in touch with us. 3s partnership is supplier,exporter,wholesaler for cytarabine injection bp 500 mg in india .
Additional information :
- From a microbiological perspective, the item ought to be utilized quickly. If not utilized promptly, being used capacity times and conditions are the obligation of the client and would ordinarily not be longer than 24 hours at 2-8°c, unless weakening has occurred in controlled and approved aseptic conditions.
Indications
- Pallor, leucopenia and thrombocytopenia of non-threatening etiology (e.g. bone marrow aplasia), unless the advantages exceed the hazard.
- Degenerative and poisonous encephalopathies, particularly after the utilization of methotrexate or treatment with ionizing radiation.
- Amid pregnancy, cytarabine should just be administrated on strict sign, where the advantages of the medication to the mother ought to be weighed against conceivable dangers to the baby.
Cytarabine Injection:-
| Brand Name: | Biobin 1000mg / 500mg / 100mg
|
| Contents: | Cytarabine 1000mg Injection |
| Other Brands: | - Cytosar-U, Tarabine PFS , Depocyt,AraC
|
| Manufacturer | Biochem |
Precision Anti-Cancer TherapyCytarabine Injection offers targeted and effective chemotherapy for leukemia and similar cancers in both adult and pediatric patients. With a neutral pH and clear, odorless formulation, it is suitable for intravenous, subcutaneous, or intrathecal administration as directed by healthcare professionals. Its sterile, ready-to-use presentation assures convenience and compliance with safety standards during hospital or oncology clinic use.
USP Compliant, Trusted in HospitalsThis injection meets stringent USP specifications, ensuring high quality and purity. Its manufactured for clinical environments, provided in a single-use glass vial, and approved for medicinal use. Designed for compatibility with most IV fluids, it integrates seamlessly into existing treatment protocols, supporting reliable outcomes for patients and healthcare teams.
Safe Handling and Storage ProtocolsHandling Cytarabine Injection requires specialized safety measures: always use gloves and a biological safety cabinet due to its cytotoxic nature. Store the vials below 25C, shielded from light, and never freeze to maintain efficacy. These clear guidelines help preserve product quality and protect healthcare personnel during preparation and administration.
FAQs of Cytarabine Injection:
Q: How is Cytarabine Injection administered to patients?
A: Cytarabine Injection can be given intravenously, subcutaneously, or intrathecally, depending on the treatment plan prescribed by a healthcare professional. Administration should always occur in a hospital or clinical setting, using proper cytotoxic handling precautions.
Q: What precautions must be taken while handling Cytarabine Injection?
A: As a cytotoxic drug, Cytarabine Injection must be handled with gloves and prepared inside a biological safety cabinet to protect healthcare workers from exposure and to maintain sterility.
Q: When should Cytarabine Injection be used?
A: Cytarabine Injection is used when prescribed by a qualified physician for the treatment of certain cancers, such as leukemia, in adults or children. The specific timing and dosage will be determined by your oncology care team.
Q: Where should Cytarabine Injection be stored and how should it be disposed of?
A: Store the product below 25C, protected from light, and do not freeze. Unused or expired vials should be disposed of according to local cytotoxic waste disposal guidelines to ensure safety.
Q: What processes are involved in preparing Cytarabine Injection for use?
A: Preparation involves inspecting the clear, colorless solution in the single-use vial, ensuring conditions and dose match clinical requirements, and using aseptic technique under a safety cabinet to draw up the injection.
Q: What are the main benefits of using Cytarabine Injection?
A: Cytarabine Injection is a proven, effective treatment for certain hematological cancers, offering flexibility in administration routes and compatibility with IV fluids, while ensuring patient safety through its USP-compliant, ready-to-use sterile formulation.
Q: Is Cytarabine Injection suitable for both adults and children?
A: Yes, Cytarabine Injection is used in both adults and children with leukemia or related conditions, but only under the supervision and prescription of a qualified healthcare provider.